Published on 28 May 2023 on Simply Wall St. via Yahoo Finance
Investors who take an interest in Lumos Pharma, Inc. (NASDAQ:LUMO) should definitely note that insider Daniel Farb recently paid US$3.90 per share to buy US$455k worth of the stock. That's a very solid buy in our book, and increased their holding by a noteworthy 22%.
See our latest analysis for Lumos Pharma
The Last 12 Months Of Insider Transactions At Lumos Pharma